Comparative effectiveness and acceptability of HIF prolyl-hydroxylase inhibitors versus for anemia patients with chronic kidney disease undergoing dialysis: a systematic review and network meta-analysis

Background: The comparative benefits and acceptability of HIF-PHIs for treating anemia have not been well researched to date. We sought to compare the effectiveness of 6 HIF-PHIs and 3 ESAs for the treatment of renal anemia patients undergoing dialysis. Data sources: Cochrane Central Register of Con...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Qiong, You, Minling, Huang, Weijuan, Chen, Jian, Zeng, Qinming, Jiang, Longfeng, Du, Xiuben, Liu, Xusheng, Hong, Ming, Wang, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10374033/
https://www.ncbi.nlm.nih.gov/pubmed/37521459
http://dx.doi.org/10.3389/fphar.2023.1050412

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10374033/
https://www.ncbi.nlm.nih.gov/pubmed/37521459
http://dx.doi.org/10.3389/fphar.2023.1050412

Ejemplares similares